ENDRA Life Sciences Inc., a pioneer of Thermo Acoustic Enhanced UltraSound, announced that it has completed what it considers to be a highly informative pre-submission meeting with the U.S. Food and Drug Administration related to the clinical trial design of the TAEUS liver device in support of its U.S. De Novo filing.
May 20, 2024
· 5 min read